Two Sigma Investments’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $60.3M | Buy |
4,705,901
+2,007,163
| +74% | +$25.6M | 0.05% | 421 |
|
|
2025
Q4 | $24.3M | Buy |
2,698,738
+249,131
| +10% | +$3.43M | 0.04% | 628 |
|
|
2025
Q3 | $42.3M | Buy |
2,449,607
+173,033
| +8% | +$2.13M | 0.06% | 370 |
|
|
2025
Q2 | $21.4M | Buy |
2,276,574
+283,669
| +14% | +$2.33M | 0.04% | 530 |
|
|
2025
Q1 | $14.2M | Buy |
1,992,905
+149,162
| +8% | +$1.51M | 0.03% | 622 |
|
|
2024
Q4 | $21.5M | Buy |
1,843,743
+863,363
| +88% | +$13.5M | 0.05% | 453 |
|
|
2024
Q3 | $20.1M | Buy |
980,380
+151,095
| +18% | +$3.48M | 0.05% | 482 |
|
|
2024
Q2 | $18.6M | Buy |
829,285
+214,717
| +35% | +$5.11M | 0.04% | 487 |
|
|
2024
Q1 | $16.9M | Buy |
614,568
+106,681
| +21% | +$2.96M | 0.04% | 487 |
|
|
2023
Q4 | $15.5M | Buy |
507,887
+343,897
| +210% | +$9.88M | 0.04% | 504 |
|
|
2023
Q3 | $5.19M | Buy |
163,990
+121,090
| +282% | +$4.7M | 0.01% | 890 |
|
|
2023
Q2 | $1.75M | Sell |
42,900
-97,258
| -69% | -$3.94M | ﹤0.01% | 1529 |
|
|
2023
Q1 | $5.22M | Sell |
140,158
-60,256
| -30% | -$2.36M | 0.02% | 883 |
|
|
2022
Q4 | $6.99M | Buy |
200,414
+108,819
| +119% | +$5.17M | 0.02% | 696 |
|
|
2022
Q3 | $5.13M | Sell |
91,595
-328,908
| -78% | -$20.4M | 0.02% | 742 |
|
|
2022
Q2 | $21.8M | Sell |
420,503
-57,750
| -12% | -$2.93M | 0.07% | 310 |
|
|
2022
Q1 | $34.8M | Buy |
478,253
+280,092
| +141% | +$23.7M | 0.1% | 249 |
|
|
2021
Q4 | $23.4M | Sell |
198,161
-111,993
| -36% | -$14M | 0.06% | 425 |
|
|
2021
Q3 | $41.6M | Buy |
310,154
+263,312
| +562% | +$39.9M | 0.11% | 241 |
|
|
2021
Q2 | $7.58M | Sell |
46,842
-299,862
| -86% | -$23.3M | 0.02% | 966 |
|
|
2021
Q1 | $27.8M | Buy |
346,704
+62,566
| +22% | +$4.2M | 0.08% | 319 |
|
|
2020
Q4 | $15.5M | Buy |
284,138
+35,118
| +14% | +$1.28M | 0.05% | 447 |
|
|
2020
Q3 | $4.95M | Sell |
249,020
-22,994
| -8% | -$479K | 0.02% | 799 |
|
|
2020
Q2 | $5.72M | Buy |
272,014
+112,820
| +71% | +$1.92M | 0.03% | 598 |
|
|
2020
Q1 | $1.95M | Sell |
159,194
-124,293
| -44% | -$1.67M | 0.02% | 978 |
|
|
2019
Q4 | $4.16M | Buy |
283,487
+195,233
| +221% | +$2.72M | 0.01% | 1077 |
|
|
2019
Q3 | $1.18M | Sell |
88,254
-24,567
| -22% | -$392K | ﹤0.01% | 1846 |
|
|
2019
Q2 | $1.85M | Buy |
+112,821
| New | +$1.77M | 0.01% | 1495 |
|
|
2019
Q1 | – | Sell |
-148,261
| Closed | -$2.02M | – | 3415 |
|
|
2018
Q4 | $2.02M | Buy |
+148,261
| New | +$2.76M | 0.01% | 1234 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
